돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 8374생성일: 2026년 10월 23일

Diisopropylethylamine → N-[4-(8-Methyl-imidazo[1,2-a]pyridin-2-yl)-phenyl]-3-piperidin-1-yl-propionamide

https://huagongshe.com/ko/reaction/8374

반응식

참여 물질

역할이름HCID투입량
반응물DiisopropylethylamineHCID 81531—
반응물1-Piperidinepropanoic acidHCID 117782—
반응물1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 2723939—
반응물4-{8-Methylimidazo[1,2-a]pyridin-2-yl}anilineHCID 2771077—
반응물1-Hydroxybenzotriazole hydrateHCID 2796029—
용매DimethylformamideHCID 6228—
용매DichloromethaneHCID 6344—
생성물N-[4-(8-Methyl-imidazo[1,2-a]pyridin-2-yl)-phenyl]-3-piperidin-1-yl-propionamideHCID 2201560723.9%

반응 단계

To a mixture of the product of Step B (330 mg) and N,N-diisopropylethylamine (0.28 mL) in dichloromethane (3 mL) and N,N-dimethylformamide (1 mL), was added 1-piperidinepropionic acid (256 mg), WSC.HCl (1-Ethyl-3-(3′dimethylaminopropyl)-carbodiimide.HCl) (312 mg), and 1-hydroxybenzotriazole hydrate (220 mg). The solution was stirred at ambient temperature for approximately 18 hours. The mixture was poured into a separatory funnel and washed sequentially with an equal volume of 1 N sodium hydroxide and water. The organic phase was dried over sodium sulfate, decanted and evaporated. The residue was purified via silica gel chromatography (methanol/dichloromethane) to yield the title compound (128 mg).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07087757B2
출처 데이터셋uspto-grants-2006_08
ORD IDord-e9297e9f797943d9b05989f796ddd673
출처 메모uspto-grants-2006_08